在AML进展过程中,TKT通过RBKS调节酸通路,促进AML进展期间的上皮细胞-介质细胞过渡
Feifan Li1, Jiaqi Liu2, Yinghua Geng3
1Graduate Department, Bengbu Medical University, 2600 Donghai Avenue, Bengbu, Anhui Province, 233030, China.
Journal of bioenergetics and biomembranes
|June 18, 2025
概括
胺 thiazole 激酶 (TKT) 通过通过 RBKS 调节酸通路,促进急性髓性白血病 (AML) 的进展,这表明 TKT 是AML的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 急性髓性白血病 (AML) 是一种危及生命的血液性恶性瘤.
- 提氨酸 thiazole kinase (TKT) 表达的增加与恶性瘤进展有关.
- 在AML病变发生过程中,TKT的确切作用需要进一步研究.
研究的目的:
- 阐明TCT有助于AML进展的机制.
- 调查TKT,RBKS和AML中的酸通路之间的关系.
- 评估TKT作为AML的潜在治疗点.
主要方法:
- 在AML患者和细胞系中量化TKT表达.
- 评估TKT对AML细胞增殖,迁移和通过过度表达和淘汰的入侵的影响.
- 确定TKT与RBKS的上游/下游相互作用及其对酸通路的调节的机制研究.
主要成果:
- 在AML患者和细胞中,TKT表达升高.
- 过度表达TKT增强了AML细胞的增殖,迁移和入侵;TKT倒置逆转了这些影响.
- TKT在RBKS的上游作用,促进AML细胞生长和调节酸通路.
- 酸通路对于AML细胞中的上皮-介质酶转换 (EMT) 具有关键作用.
结论:
- 通过RBKS介导的酸路径调节,TKT通过增强EMT促进AML的进展.
- TKT代表了AML治疗的新型治疗标.
相关概念视频
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
MAPK Signaling Cascades
6.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K
Receptor Tyrosine Kinases
14.4K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K


